How AI is helping solve the labor issue in treating rare diseases
Modern biotech has the tools to edit genes and design drugs, yet thousands of rare diseases remain untreated.…
A safer gene-editing tool shows promise for transthyretin amyloidosis treatment
Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin…
Biographica nets $9.5m for AI-led crop design, partners with BASF
Biographica, a startup deploying AI and machine learning to accelerate and improve the crop trait development process by…
Why Changing Plant Genes Is Still Slow and How Scientists Are Speeding It Up
Even with CRISPR and advanced sequencing, altering plant behavior remains labor-intensive. A new approach aims to reveal how…
Scientists make breakthrough that could give major boost to food supply: ‘A huge positive’
Scientists at the University of Guelph in Ontario, Canada, have developed a gene editing technique that improves canola…
Scientists Want to Snip Your Genes to Fix High Cholesterol Levels
GETTING A DIAGNOSIS of high cholesterol is not fun. It requires a revamp of lifestyle basics like how…
CRISPR-edited fungus boosts protein production and cuts environmental impact
In a new study publishing November 19 in the Cell Press journal Trends in Biotechnology, researchers used a…
Switching APOE4 to APOE2 in adult mice reduces Alzheimer’s pathology and improves memory
By flipping a single genetic switch from APOE4 to APOE2 in adult mice, researchers reversed key Alzheimer’s-like changes…
New ‘wonder drug’ could cut your cholesterol in half
Scientists say a cutting-edge gene-editing treatment could help people cut harmful high cholesterol levels in half — just…
One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trial
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and…
New gene-editing method can correct many disease-causing mutations in mammalian cells
Some genetic disorders-such as cystic fibrosis, hemophilia and Tay Sachs disease-involve many mutations in a person’s genome, often…
After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results
As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in…